You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm reported that it had not received any revenues in the quarter tied to system sales. It had announced separately yesterday that it will reposition its focus on the molecular diagnostics industry.
The firm said that it expects to save $4 million to $5 million annually following the restructuring.
The firm will increase its focus on providing diagnostics services while aiming to trim its burn rate by 40 to 60 percent.
While most companies working in the RNAi drugs field have been able to secure the money needed to maintain operations, a number of players in the space have bowed out under unfavorable circumstances.
President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.
Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.
The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.
In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.